Veracyte (NASDAQ:VCYT) initiated with Buy rating and $33 (15% upside) price target at Needham.
PRA Health Sciences (NASDAQ:PRAH) initiated with Market Perform rating and $105 (7% upside) price target at SVB Leerink.
Bio-Techne (NASDAQ:TECH) upgraded to Buy with a $270 (29% upside) price target at Janney Montgomery.
Dova Pharmaceuticals (NASDAQ:DOVA) upgraded to Outperform at Evercore ISI. Shares up 5% premarket.
Teladoc (NYSE:TDOC) removed from Franchise Pick List at Jefferies.
Stryker (NYSE:SYK) downgraded to In Line with a $210 (2% upside) price target at Evercore ISI.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.